| Application no. and date | 02804105.1 (espacenet) (Federated) (European Patent Register), 20021011 | | Patent/reg. no. and date | DK/EP 1434791, 20091007 | | Publication date | 20040707 | | Priority no. and date | US 328624 P, 20011011, US 414155 P, 20020927, US 269695, 20021010 | | EP pub. no. and date |
EP 1434791 20040707 | | Effective date | | | Applicant/owner | Amgen, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | P18051DKEP | | Inventor | MIN, Hosung, 3875 Conner Court
Newbury Park, CA 91320, US,
OLINER, Jonathan, Daniel, 959 Golden Crest Avenue
Newbury, CA 91320, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | C07K 1/00 (2006.01) , C07K 14/00 (2006.01) , C07K 5/00 (2006.01) | | Title | Specifikke bindingsmidler til human angiopoietin-2 | | Int. application no. | US2002032657 | | Int. publication no. | WO2003057134 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
